Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer

Published:2015-02 Issue: Volume:69 Page:301-305
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Shen Hua,Shen Jianxin,Wang Lin,Shi Zhumei,Wang Min,Jiang Bing-hua,Shu Yongqian

Funder

National Natural Science Foundation of China

Jiangsu Province Clinical Science and Technology Projects

Priority Academic Program Development of Jiangsu Higher Education Institutions

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference26 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

3. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung;Kato;N Engl J Med,2004

4. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

5. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes miR-24-3p Target S1PR1 to Promote Angiogenesis and Induce Tumor Metastasis in non-small cell lung cancer;2023-12-06

2. Integrated bioinformatics analysis of microarray data from non-small cell lung cancer;Cellular and Molecular Biology;2023-07-31

3. Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics;Molecular Therapy;2022-11

4. Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment;Heliyon;2022-10

5. Contributions of Circulating microRNAs for Early Detection of Lung Cancer;Cancers;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3